Clinical Pathways
Clinical Pathways in Oncology Video Series (Part 1): Leveraging and Developing Pathways for Value-Based Care
Panel
Sophia Humphreys, PharmD, MHA, BCBBS
Executive Director, Pharmacy
Credena Health – Specialty Pharmacy, Division of Providence Health
Evan Slater, PharmD
Director, Pharmacy and Admixture Services
Rocky Mountain Cancer Centers – Central Business Office
Clinical Pathways
Clinical Pathways in Oncology: Perspectives on Clinical Pathways in Oncology
Top factors defining value when developing and implementing clinical pathways for oncology
Care Delivery
New Directions in Value-Based Care in Oncology: Finding Common Ground Through Stakeholder Collaboration (part 1)
Panel
Adam S. Kittai
Hematology/Oncology
David Larsen, RN, MHA,
Former Director of Quality Improvement
Select Health
Victoria Nachar, PharmD, BCOP,
Hematology Clinical Pharmacist Specialist
University of Michigan Rogel Cancer Center
Jay Weaver, PharmD, MPH,
Former Chief Pharmacy Officer
Blue Cross Blue Shield of Kansas City
Care Delivery
Value-Based Care in Oncology: Collaborating to Optimize Patient Outcomes (part 2)
Panel
Adam S. Kittai
Hematology/Oncology
Victoria Nachar, PharmD, BCOP,
Hematology Clinical Pharmacist Specialist
University of Michigan Rogel Cancer Center
Jay Weaver, PharmD, MPH,
Former Chief Pharmacy Officer
Blue Cross Blue Shield of Kansas City
Policy Updates
Understanding the Enhancing Oncology Model (EOM):
Implications for Future Management
Panel
Ray Bailey, RPh, Consultant
Formerly of Florida Cancer Specialists
Victoria Nachar, PharmD, BCOP
Hematology Clinical Pharmacist Specialist
University of Michigan Rogel Cancer Center
Jay Weaver, PharmD, MPH
Former Chief Pharmacy Officer
Blue Cross Blue Shield of Kansas City
Care Delivery
Strength in Numbers:
How Oncology Practice Consolidation Is Impacting Care Delivery
Panel
James Gilmore, PharmD
Chief Pharmacy and Clinical Services Officer
American Oncology Network (AON)
Ray Bailey, RPh, Consultant
Formerly of Florida Cancer Specialists
Healthcare Disparities in the Treatment of CLL/SLL:
A Real-World Analysis of SEER Data
Guest Speaker
Adam S. Kittai
Hematology/Oncology
Care Delivery
Optimizing Outcomes in the Management of CLL:
The Evolving Role of the Clinical Pharmacist
Panel
John Allan, MD
Hematology/Oncology
Victoria Nachar, PharmD, BCOP,
Hematology Clinical Pharmacist Specialist
University of Michigan Rogel Cancer Center